Signaling pathways
-
BA8878 NingetinibSummary: A potent orally bioavailable small molecule tyrosine kinase inhibitor. - BA8879 BozitinibSummary: Bozitinib (PLB-1001) is a highly selective kinase inhibitor that crosses the blood-brain barrier.
- BA8880 CEP-40783Summary: CEP-40783 is a highly selective, orally active inhibitor.
- BA8881 FosgonimetonSummary: It is an agonist of the hepatocyte growth factor receptor.
- BA8883 RisvodetinibSummary: Risvodetinib (IkT-148009) is an orally active, selective, and brain-permeable inhibitor of.
- BA8884 TunlametinibSummary: Tunlametinib is an anti-tumor compound.
-
BA8885 S49076Summary: S49076 is a novel and efficient inhibitor. - BA8886 BPI-9016MSummary: BPI-9016M is a potent, orally active, selective dual and tyrosine kinase inhibitor.
- BA8887 JNJ-38877618Summary: JNJ-38877618 is an effective.
- BA8888 SYN1143Summary: SYN1143 is a potent, selective and orally active dual inhibitor.